Skip to main content
SpringerLink
Log in

Skin Aging and Menopause

Implications for Treatment

  • Current Opinion
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

The skin is one of the largest organs of the body, which is significantly affected by the aging process and menopause. The significant changes sustained by the skin during the menopause are due to the effect sustained on the skin’s individual components.

The estrogen receptor has been detected on the cellular components of the skin. Accordingly, dermal cellular metabolism is influenced by the hypoestrogenoemic state of menopause leading to changes in the collagen content, alterations in the concentration of glycoaminoglycans and most importantly the water content. Consequently changes in these basic components leads to an alteration in function compatible with skin aging.

Changes in the skin collagen leads to diminished elasticity and skin strength. Collagen content may be measured by various methods such as direct skin biopsy, skin blister assessment for collagen markers and skin thickness measurement. All these variables indicate a reduction in collagen content following menopause. This may be reversed with the administration of estrogen given both topically and systemically.

A reduction in hydrophilic glycoaminglycans leads to a direct reduction in water content, which influences the skin turgor. These effects on glycoaminoglycans, due to the hypoestrogenia, have been clearly shown in animal studies and appeared to be rapidly reversed with the application of estrogens. The sum total of these basic effects on the skin leads to wrinkles, the skin condition typifying skin aging.

Structures resident in the skin are likewise influenced by menopause. Changes to the cutaneous vascular reactivity are noted following menopause. Capillary blood flow velocity decreases significantly in postmenopausal women. Postmenopausal flushing is due to profound vasodilatation in the dermal papillae. Hair growth is also influenced by the hormonal milieu and consequently hair loss has been associated with the beginning of menopause.

Treatments administered for menopause, in particular hormone replacement therapy, appear to alter its effects on the basic components of the skin as well as the more complex structures residing in the skin, consequently retarding the skin aging process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Raine-Fenning NJ, Sant RA, Brincat MP. HRT in the new millennium. Contemp Clin Gynecol & Obstets 2001; 1 (1): 7–23

    Google Scholar 

  2. Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol 2001; 45: S116–S124

    Article  PubMed  CAS  Google Scholar 

  3. Punnonen R, Lovgren T, Kouvonen I. Demonstration of estrogen receptors in the skin. J Endocrinol Invest 1980; 3 (3): 217–221

    Google Scholar 

  4. Alberts B, Bray D, Lewis J, et al. Molecular biology of the Cell. 3rd ed. New York: Garland Publishing Inc, 1994

    Google Scholar 

  5. Jemec GB, Bhogal BS, Wojnarowska F. Are acquired nevi oestrogen-dependent tumours? Acta Derm Venereol 1987; 67 (5): 451–453

    PubMed  CAS  Google Scholar 

  6. Jemec GB, Wojnarowska F. The distribution of p29 protein in normal human skin. Br J Dermatol 1987; 117 (2): 217–224

    Article  PubMed  CAS  Google Scholar 

  7. MacLean AB, Nicol LA, Hodgins MB. Immunohistochemical localization of estrogen receptors in the vulva and vagina. J Reprod Med 1990; 35 (11): 1015–1016

    PubMed  CAS  Google Scholar 

  8. Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990; 30 (2): 97–100

    Article  PubMed  CAS  Google Scholar 

  9. Albright F, Bloomberg E, Smith PH. Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940; 55: 298–305

    CAS  Google Scholar 

  10. McConkey B, Fraser GR, Bligh AS, et al. Transparent skin and osteoporosis. Lancet 1963; I: 693–695

    Article  Google Scholar 

  11. Brincat M, Moniz CJ, Studd JW, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985; 92 (3): 256–259

    Article  PubMed  CAS  Google Scholar 

  12. Rauramo L, Punnonen R. Effect of oral estrogen treatment with estriol succinate on the skin of castrated women. Z Haut Geschlechtskr 1969; 44 (13): 463–470

    PubMed  CAS  Google Scholar 

  13. Punnonen R. On the effect of castration and peroral estrogen therapy on the skin. Acta Obstet Gynecol Scand 1971; 9 Suppl. 9: 32

    Google Scholar 

  14. Pierard-Franchimont C, Cornil F, Dehavey J, et al. Climacteric skin ageing of the face: a prospective longitudinal comparative trail on the effect of oral hormone replacement therapy. Maturitas 1999; 32: 87–93

    Article  PubMed  CAS  Google Scholar 

  15. Tan CY, Statham B, Marks R, et al. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol 1982; 106 (6): 657–667

    PubMed  CAS  Google Scholar 

  16. Haapasaari KM, Raudaskoski T, Kallioinen M, et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas 1997; 27: 153–162

    Article  PubMed  CAS  Google Scholar 

  17. Chen L, Dyson M, Rymer J, et al. The use of high frequency diagnostic ultrasound to investigate the effect of hormone replacement therapy on skin thickness. Skin Res Technol 2001; 7: 95–97

    Article  PubMed  CAS  Google Scholar 

  18. Maheux R, Naud F, Rioux M, et al. A randomized, double-blind, placebocontrolled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 1994; 170 (2): 642–649

    PubMed  CAS  Google Scholar 

  19. Black MM, Bottoms E, Shuster S. Skin collagen content and thickness in systemic sclerosis. Br J Dermatol 1970; 83 (5): 552–555

    Article  PubMed  CAS  Google Scholar 

  20. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975; 93 (6): 639–643

    Article  PubMed  CAS  Google Scholar 

  21. Brincat M, Moniz CF, Studd JW, et al. Sex hormones and skin collagen content in postmenopausal women. Br Med J (Clin Res Ed) 1983; 287 (6402): 1337–1338

    Article  CAS  Google Scholar 

  22. Sauerbronn A VD, Fonseca AM, Bagnoli VR, et al. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000; 68: 35–41

    Article  PubMed  CAS  Google Scholar 

  23. Oikarinen A. Systemic estrogens have no conclusive beneficial effect on human skin connective tissur. Acta Obstet Gynaecol Scand 2000; 79: 250–254

    Article  CAS  Google Scholar 

  24. Savvas M, Bishop J, Laurent G, et al. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br J Obstet Gynaecol 1993; 100 (2): 154–156

    Article  PubMed  CAS  Google Scholar 

  25. Brincat M, Versi E, O’Dowd T, et al. Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas 1987; 9 (1): 1–5

    Article  PubMed  CAS  Google Scholar 

  26. Shahrad P, Marks R. A pharmacological effect of oestrone on human epidermis. Br J Dermatol 1977; 97 (4): 383–386

    Article  CAS  Google Scholar 

  27. Holland EF, Studd JW, Mansell JP, et al. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet Gynecol 1994; 83 (2): 180–183

    PubMed  CAS  Google Scholar 

  28. Brincat M, Moniz CF, Kabalan S, et al. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynaecol 1987; 94 (2): 126–129

    Article  PubMed  CAS  Google Scholar 

  29. Varila E, Rantala I, Oikarinen A, et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 1995; 102 (12): 985–989

    Article  PubMed  CAS  Google Scholar 

  30. Black MM, Shuster S, Bottoms E. Osteoporosis, skin collagen, and androgen. BMJ 1970; 4 (738): 773–774

    Article  PubMed  CAS  Google Scholar 

  31. Shuster S, Black MM, Bottoms E. Skin collagen and thickness in women with hirsuties. BMJ 1970; 4 (738): 772

    Article  PubMed  CAS  Google Scholar 

  32. Hall DA, Reed FB, Nuki G, et al. The relative effects of age and corticosteroid therapy on the collagen profiles of dermis from subjects with rheumatoid arthritis. Age Ageing 1974; 3 (1): 15–22

    Article  PubMed  CAS  Google Scholar 

  33. Danforth DN, Veis A, Breen M, et al. The effect of pregnancy and labor on the human cervix: changes in collagen, glycoproteins, and glycosaminoglycans. Am J Obstet Gynecol 1974; 120 (5): 641–651

    PubMed  CAS  Google Scholar 

  34. Grosman N, Hvidberg E, Schou J. The effect of oestrogenic treatment on the acid mucopolysaccharide pattern in skin of mice. Acta Pharmacol Toxicol 1971; 30 (5): 458–464

    Article  CAS  Google Scholar 

  35. Lim SC, Caballero AE, Arora S, et al. The effect of hormonal replacement therapy on the vascular reactivity and ebdothelial function of healthy individuals and individuals with type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 4159–4164

    Article  PubMed  CAS  Google Scholar 

  36. Arora S, Veves A, Caballaro AE, et al. Estrogen improves endothelial function. J Vasc Surg 1998; 27 (6): 1141–1146

    Article  PubMed  CAS  Google Scholar 

  37. Harvell J, Hussona-Saeed I, Maibach HI. Changes in transepidermal water loss and cutaneous blood flow during the menstrual cycle. Contact Dermatitis 1992; 27 (5): 294–301

    Article  PubMed  CAS  Google Scholar 

  38. Haenggi W, Linder HR, Birkhaeuser MH, et al. Microscopic findings of the nail-fold capillaries: dependence on menopausal status and hormone replacement therapy. Maturitas 1995; 22 (1): 37–46

    Article  PubMed  CAS  Google Scholar 

  39. Brooks EM, Morgan AL, Pierzga JM, et al. Chronic hormone replacement therapy alters thermoregulatory and vasomotor function in postmenopausal women. J Appl Physiol 1997; 83 (2): 477–484

    PubMed  CAS  Google Scholar 

  40. Ginsburg J, Hardiman P, O’Reilly B. Peripheral blood flow in menopausal women who have hot flushes and in those who do not. BMJ 1989; 298 (6686): 1488–1490

    Article  PubMed  CAS  Google Scholar 

  41. Brincat M, de Trafford JC, Lafferty K, et al. Peripheral vasomotor control and menopausal flushing: a preliminary report. Br J Obstet Gynaecol 1984; 91 (11): 1107–1110

    Article  PubMed  CAS  Google Scholar 

  42. Brincat M, Kabalan S, Studd JW, et al. A study of the decrease of skin collagen content, skin thickness and bone mass in the postmenopausal woman. Obstet Gynaecol 1987; 70: 840–845

    CAS  Google Scholar 

  43. Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999; 33: 239–247

    Article  PubMed  CAS  Google Scholar 

  44. Shah MG, Maibach HI. Estrogen and skin: an overview. Am J Clin Dermatol 2001; 2: 143–150

    Article  PubMed  CAS  Google Scholar 

  45. Varila E, Sievanen H, Vuori I, et al. Limited value of ultrasound measured skin thickness in predicting bone mineral density in peri- and postmenopausal women. Maturitas 1995; 21 (1): 45–49

    Article  PubMed  CAS  Google Scholar 

  46. Shelley WB, Shelley ED, Talanin NY, et al. Estrogen dermatitis. J Am Acad Dermatol 1995; 32 (1): 25–31

    Article  PubMed  CAS  Google Scholar 

  47. Leylek OA, Unlu S, Ozturkcan S, et al. Estrogen dermatitis. Eur J Obstet Gynecol Reprod Biol 1997; 72 (1): 97–103

    Article  PubMed  CAS  Google Scholar 

  48. Kim KH, Yoon TJ, Oh CW, et al. A case of estrogen dermatitis. J Dermatol 1997; 24 (5): 332–336

    PubMed  CAS  Google Scholar 

  49. Paquet F, Pierard-Franchimont C, Fumal I, et al. Sensitive skin at menopause; dew point and electrometric properties of the stratum corneum. Maturitas 1998; 28 (3): 221–227

    Article  PubMed  CAS  Google Scholar 

  50. O’Neill S, Kirkegard Y. An Australian experience of transdermal oestradiol patches in a subtropical climate. Aust N Z J Obstet Gynaecol 1993; 33 (3): 327–329

    Article  PubMed  Google Scholar 

  51. McCarthy T, Dramrusic V, Ratnam S. Use of two types of estradiol-releasing skin patches for menopausal patients in a tropical climate. Am J Obstet Gynecol 1992; 166 (6 Pt 2): 2005–2010

    PubMed  CAS  Google Scholar 

  52. Corson SL. Clinical experience with Systen, a new transdermal form of hormone replacement therapy. Int J Fertil Menopausal Stud 1993; 38 Suppl. 1: 36–44

    PubMed  Google Scholar 

  53. Wallace ML, Smoller BR. Estrogen and progesterone receptors in androgenic alopecia versus alopecia areata. Am J Dermatopathol 1998; 20 (2): 160–163

    Article  PubMed  CAS  Google Scholar 

  54. Oh HS, Smart RC. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA 1996; 93 (22): 12525–12530

    Article  PubMed  CAS  Google Scholar 

  55. Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol 1997; 36 (1): 59–66

    Article  PubMed  CAS  Google Scholar 

  56. Schmidt JB, Binder M, Macheiner W, et al. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds: a pilot study. Maturitas 1994; 20 (1): 25–30

    Article  PubMed  CAS  Google Scholar 

  57. Anttinen H, Orava S, Ryhanen L, et al. Assay of protocollagen lysyl hydroxylase activity in the skin of human subjects and changes in the activity with age. Clin Chim Acta 1973; 47 (2): 289–294

    Article  PubMed  CAS  Google Scholar 

  58. Henry F, Pierard-Franchimont C, Cauwenbergh G, et al. Age-related changes in facial skin contours and rheology. J Am Geriatr Soc 1997; 45 (2): 220–222

    PubMed  CAS  Google Scholar 

  59. Dunn LB, Damesyn M, Moore AA, et al. Does estrogen prevent skin aging? Results from the First National Health and Nutrition Examination Survey (NHANES I). Arch Dermatol 1997; 133 (3): 339–342

    Article  PubMed  CAS  Google Scholar 

  60. Pierard GE, Letawe C, Dowlati A, et al. Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995; 43 (6): 662–665

    PubMed  CAS  Google Scholar 

  61. Sator PG, Schmidt JB, Sator MO, et al. The influence of hormone replacement therapy on skin ageing: a pilot study Maturitas 2001; 39: 43–55

    Google Scholar 

  62. Castelo-Branco C, Figueras F, Martinez de Osaba MJ, et al. Facial wrinkling in postmenopausal women: effects of smoking status and hormone replacement therapy. Maturitas 1998; 29 (1): 75–86

    Article  PubMed  CAS  Google Scholar 

  63. Ramamrurthy NS, McClain SA, Pirila E, et al. Wound healing in aged normal and ovariectomised rats: effects of chemically modified doxycycline (CMT-8) on MMP expression and collagen synthesis. Ann NY Acad Sci 1999; 878: 720–723

    Google Scholar 

  64. Pirila E, Ramamrurthy N, Maisi P, et al. Wound healing in ovariectomised rats: effects of chemically modified tetracyclinr (VMT -8) and estrogen on matrix metalloproteinases-8, -13 and type I collagen expression. Curr Med Chem 2001; 8: 281–294

    Article  PubMed  CAS  Google Scholar 

  65. Ashcroft GS, Greenwelk-Wild T, Horan MA, et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999; 155: 1137–1146

    Google Scholar 

  66. Ashcroft GS, Dodsworth J, van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-betal levels. Nat Med 1997; 3 (11): 1209–1215

    Article  PubMed  CAS  Google Scholar 

  67. Schmidt JB, Binder M, Macheiner W, et al. New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin. Int J Dermatol 1995; 34 (1): 53–57

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. Academic Division of Reproductive Medicine, University of Nottingham, Nottingham, UK

    Nicholas J. Raine-Fenning

  2. Department of Obstetrics and Gynaecology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta

    Mark P. Brincat & Yves Muscat-Baron

Authors
  1. Nicholas J. Raine-Fenning
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark P. Brincat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yves Muscat-Baron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark P. Brincat.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raine-Fenning, N.J., Brincat, M.P. & Muscat-Baron, Y. Skin Aging and Menopause. Am J Clin Dermatol 4, 371–378 (2003). https://doi.org/10.2165/00128071-200304060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200304060-00001

Keywords

Search

Navigation